| Literature DB >> 32203383 |
Rafael Pinilla-Redondo1,2,3, Bálint Csörgő1,4, Nicole D Marino1, Joseph Bondy-Denomy5,6,7.
Abstract
Clustered, regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes, a diverse family of prokaryotic adaptive immune systems, have emerged as a biotechnological tool and therapeutic. The discovery of protein inhibitors of CRISPR-Cas systems, called anti-CRISPR (Acr) proteins, enables the development of more controllable and precise CRISPR-Cas tools. Here we discuss applications of Acr proteins for post-translational control of CRISPR-Cas systems in prokaryotic and mammalian cells, organisms and ecosystems.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32203383 PMCID: PMC8510557 DOI: 10.1038/s41592-020-0771-6
Source DB: PubMed Journal: Nat Methods ISSN: 1548-7091 Impact factor: 28.547